Literature DB >> 13606949

Antagonism of nicotine-induced convulsions by ganglionic blocking agents.

C A STONE, K L MECKELNBURG, M L TORCHIANA.   

Abstract

Entities:  

Keywords:  AUTONOMIC DRUGS/effects; CONVULSIONS/experimental; NICOTINE/effects

Mesh:

Substances:

Year:  1958        PMID: 13606949

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


× No keyword cloud information.
  8 in total

1.  Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats.

Authors:  T Marenco; S Bernstein; P Cumming; P B Clarke
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Effects of ganglion blocking agents on nicotine extensor convulsions and lethality in mice.

Authors:  M D Aceto; H C Bentley; J R Dembinski
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

3.  Some effects of nicotine on food and water intake in undeprived rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

4.  Characterization of the locomotor stimulant action of nicotine in tolerant rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

5.  Chronic central nicotinic blockade after a single administration of the bisquaternary ganglion-blocking drug chlorisondamine.

Authors:  P B Clarke
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

6.  The ganglion-blocking activity of aminobicyclo[2,2,1]heptanes (congeners of mecamylamine) and bicyclo[3,2,1]azaoctanes (bridged congeners of pempidine).

Authors:  N D Edge; S J Corne; G E Lee; W R Wragg
Journal:  Br J Pharmacol Chemother       Date:  1960-06

7.  1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.

Authors:  I L Bonta; C J De Vos; H Grijsen; F C Hillen; E L Noach; A W Sim
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

8.  Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.

Authors:  L Harris; D Stitcher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.